Debridement,Antibiotics and Implant Retention in Early Periprosthetic Joint Infection

Abstract

Introduction

Periprosthetic joint infection (PJI) is a devastating complication in hip arthroplasty surgery. Debridement, antibiotics (AB) and implant retention (DAIR) is recommended in early PJI in association with stable implants. The aim of this study was to evaluate the success rate of DAIR in early PJI (<4 weeks) and to identify factors predicting the outcome.

Methods

This cohort study included a consecutive series of 35 patients (median age 74 years, 25 women, 26 primary arthroplasties) treated with DAIR for an early PJI in a regional hospital.

Results

28 patients (80%) had their infection eradicated. DAIR-only eradicated the PJI in 22 (63%) patients with a median follow-up of 50 (24-84) months. In 17 (49%) patients, oral AB had been given prior to intraoperative cultures, which delayed first debridement with average 6 days and delayed hospital stay. Primary surgery for a hip fracture increased the risk of DAIR-failure. Surgical experience did not affect the outcome. 17% (n = 6) of the patients sustained a secondary infection during their hospital stay; the majority was beta-lactam resistant coagulase negative Staphylococcus aureus.

Conclusions

The success rate of DAIR was inferior to pervious controls from experienced revision centers. Hip fracture patients should be informed about the increased risk of DAIR treatment failure. In order not to delay surgery, empirically based oral AB should not be administered prior to deep cultures.

Trial registration

ClinicalTrials.gov Identifier: NCT02087020.

Keywords

Antibiotics Debridement Hip arthroplasty Implant retention Outcome Periprosthetic joint infection

Get full access to this article

View all access options for this article.

References

Dale

Fenstad

Hallan

et al.

Increasing risk of prosthetic joint infection after total hip arthroplasty.

Acta Orthop 2012;83(5):449–458

Vessely

Whaley

Harmsen

Schleck

Berry

The Chitranjan Ranawat Award: Long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties.

Clin Orthop Relat Res 2006;452:28–34

Garellick

Kärrholm

Rogmark

Rolfson

Herberts

Swedish Hip Arthroplasty Register Annual Report 2011.

http://www.shpr.se/Libraries/Documents/Årsrapport_2011_avseende_verksamhetsåret_2011.sflb.ashx. Accessed 2011-10-27.

Drancourt

Stein

Argenson

Zannier

Curvale

Raoult

Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.

Antimicrob Agents Chemother 1993;37(6):1214–1218

Tsukayama

Estrada

Gustilo

Infection after total hip arthroplasty.

A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 1996;78(4):512–523

Brandt

Sistrunk

Duffy

et al.

Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention.

Clin Infect Dis 1997;24(5):914–919

Crockarell

Hanssen

Osmon

Morrey

Treatment of infection with débridement and retention of the components following hip arthroplasty.

J Bone Joint Surg Am 1998;80(9):1306–1313

Zimmerli

Widmer

Blatter

Frei

Ochsner

Foreign-Body Infection Study G.

Role of rifampin for treatment of orthopedic implant-related staphylococcal infections - A randomized controlled trial. JAMA 1998;279(19):1537–1541

Barberán

Aguilar

Carroquino

et al.

Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.

Am J Med 2006;119(11):993.e7–993.e10

10.

Choong

PFM

Dowsey

Carr

Daffy

Stanley

Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen.

Acta Orthop 2007;78(6):755–765

11.

Van Kleunen

Knox

Garino

Lee

Irrigation and débridement and prosthesis retention for treating acute periprosthetic infections.

Clin Orthop Relat Res 2010;468(8):2024–2028

12.

Mikkelsen

Pedersen

Højbjerg

Schønheyder

Culture of multiple peroperative biopsies and diagnosis of infected knee arthroplasties.

APMIS 2006;114(6):449–452

13.

Hozack

Parvizi

New definition for periprosthetic joint infection.

J Arthroplasty 2011;26(8):1135

14.

Segawa

Tsukayama

Kyle

Becker

Gustilo

Infection after total knee arthroplasty.

A retrospective study of the treatment of eighty-one infections. J Bone Joint Surg Am 1999;81(10):1434–1445

15.

Peel

Buising

Dowsey

et al.

Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy.

Antimicrob Agents Chemother 2013;57(1):350–355

16.

Puhto

Syrjala

Short-course antibiotics for prosthetic joint infections treated with prosthesis retention.

Clin Microbiol Infect 2012;18(11):1143–1148

17.

Sukeik

Patel

Haddad

Aggressive early débridement for treatment of acutely infected cemented total hip arthroplasty.

Clin Orthop Relat Res 2012;470(11):3164–3170

18.

Westberg

Grøgaard

Snorrason

Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years.

Acta Orthop 2012;83(3):227–232

19.

Marculescu

Berbari

Hanssen

et al.

Outcome of prosthetic joint infections treated with debridement and retention of components.

Clin Infect Dis 2006;42(4):471–478

20.

Kuiper

Vos

Saouti

et al.

Prosthetic joint-associated infections treated with DAIR (debridement, antibiotics, irrigation, and retention): analysis of risk factors and local antibiotic carriers in 91 patients.

Acta Orthop 2013;84(4):380–386

21.

Zimmerli

Trampuz

Ochsner

Prosthetic-joint infections.

N Engl J Med 2004;351(16):1645–1654

22.

Davis

Management of bone and joint infections due to Staphylococcus aureus.

Intern Med J 2005;35Suppl 2:S79–96

23.

Tattevin

Crémieux

Pottier

Huten

Carbon

Prosthetic joint infection: when can prosthesis salvage be considered?

Clin Infect Dis 1999;29(2):292–295

24.

Spangehl

Masri

O'Connell

Duncan

Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties.

J Bone Joint Surg Am 1999;81(5):672–683

25.

Dale

Fenstad

Hallan

et al.

Increasing risk of prosthetic joint infection after total hip arthroplasty.

Acta Orthop 2012;83(5):449–458

26.

Trampuz

Hanssen

Osmon

Mandrekar

Steckelberg

Patel

Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection.

Am J Med 2004;117(8):556–562

27.

Laffer

Graber

Ochsner

Zimmerli

Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre.

Clin Microbiol Infect 2006;12(5):433–439

28.

Giulieri

Graber

Ochsner

Zimmerli

Management of infection associated with total hip arthroplasty according to a treatment algorithm.

Infection 2004;32(4):222–228

29.

Smith

Pearson

Wilcox

et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999;340(7):493–501

30.

Kolenbrander

Palmer

Jr Periasamy

Jakubovics

Oral multispecies biofilm development and the key role of cell-cell distance.

Nat Rev Microbiol 2010;8(7):471–480

31.

Darouiche

Device-associated infections: a macroproblem that starts with microadherence.

Clin Infect Dis 2001;33(9):1567–1572

32.

Lora-Tamayo

Murillo

Iribarren

et al; REIPI Group for the Study of Prosthetic Infection. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis 2013;56(2):182–194

33.

Vilchez

Martínez-Pastor

García-Ramiro

et al.

Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement.

Clin Microbiol Infect 2011;17(3):439–444